Replies to post #791901 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Follow-up: In some English-speaking countries, the term “franchise” is sometimes used interchangeably with the more general idea of “a business.” While that usage is legally incorrect, it simply means they’re referring to having or operating a business. It’s possible someone once used the word in that informal sense, and others ran with it, turning it into a larger misconception.

[evanstony]

If other drugs lose patent protection, NWBO’s combination patents could allow it to take the lead without involving big pharma, potentially incorporating generic drugs into its own offerings on favorable terms.

Bio, this is a really important look into the future opportunities for NWBO and future problems for some of the biggest drugs BP'S are now selling. For a large BP's about to have their biggest money producers end their patent protection the Buy Out prospect is reinforced. And for NWBO the future income stream of multiple big sellers now having a generic potential combo with improved results highlights that tremendous opportunity.

IMO we will see multiple offers .... and the long wait will be more than worth it many times over!!!

[WideEyed]

Biosectinvestor,

Given your response, you're optimistic NWBO is largely in control of BPs combining DCVax-L with their immunotherapies via licensing. Great!